Ppar agonists for the treatment of hcv infection

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/216 (2006.01) A61P 31/12 (2006.01)

Patent

CA 2546247

The present invention concerns the use of PPAR.alpha. agonists in methods and compositions for the treatment or prevention of infection by the hepatitis C virus (HCV) in mammals, especially humans.

La présente invention concerne l'utilisation d'agonistes des PPAR.alpha. pour des traitements et compositions, prophylactiques comme thérapeutiques, contre le VHC (virus de l'hépatite C) chez les mammifères, et plus particulièrement les humains.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ppar agonists for the treatment of hcv infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ppar agonists for the treatment of hcv infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ppar agonists for the treatment of hcv infection will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1565841

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.